Schrodinger (SDGR) CFO receives new stock options and RSU grants

Rhea-AI Filing Summary

Schrödinger, Inc.’s EVP & CFO Rachit Jain received new equity awards. On March 2, 2026, he was granted stock options covering 34,250 shares of common stock at an exercise price of $0.0000 per share, increasing his option holdings to 34,250 shares.

He also received a grant of 17,130 restricted stock units (RSUs), each representing one share of common stock, bringing his common stock holdings to 54,227 shares, which includes 52,660 unvested RSUs. The RSUs vest in four equal annual installments on March 9 of 2027, 2028, 2029 and 2030. The options vest 25% on March 2, 2027, with the remainder vesting in equal monthly installments through March 2, 2030, in each case subject to his continued service with the company.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Jain Rachit

Role EVP & CFO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	34,250	$0.00	--
Grant/Award	Common Stock	17,130	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 34,250 shares (Direct); Common Stock — 54,227 shares (Direct)

Footnotes (1)

1. Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 2, 2026 and will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, subject to the reporting person's continued service with the company. Includes an aggregate of 52,660 unvested RSUs. The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030, subject to the reporting person's continued service with the company.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jain Rachit

(Last) (First) (Middle)

C/O SCHRODINGER, INC.,

1540 BROADWAY, 24TH FLOOR

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Schrodinger, Inc. [ SDGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/02/2026		A		17,130	A	$0	54,227(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$12.15	03/02/2026		A		34,250		(3)	03/02/2036	Common Stock	34,250	$0	34,250	D

Explanation of Responses:

1. Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 2, 2026 and will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, subject to the reporting person's continued service with the company.

2. Includes an aggregate of 52,660 unvested RSUs.

3. The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030, subject to the reporting person's continued service with the company.

Remarks:

	/s/ Donald Shum, as attorney-in-fact for Rachit Jain	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Schrodinger (SDGR) report for Rachit Jain?

Schrodinger reported that EVP & CFO Rachit Jain received equity grants, not open-market trades. He was awarded stock options and restricted stock units as part of compensation, increasing his direct holdings in options and common stock tied to future vesting.

How many stock options did Schrodinger EVP & CFO Rachit Jain receive?

Rachit Jain received stock options for 34,250 shares of Schrodinger common stock at an exercise price of zero. After this grant, his total option holdings reached 34,250 shares, all subject to the specified vesting schedule through March 2, 2030.

What RSU grant did Schrodinger (SDGR) award to EVP & CFO Rachit Jain?

He received 17,130 restricted stock units, each representing one share of Schrodinger common stock. Following this grant, he directly owns 54,227 common shares, including 52,660 unvested RSUs, all subject to future vesting and continued service requirements.

What is the vesting schedule for Rachit Jain’s Schrodinger RSUs?

The RSUs granted on March 2, 2026 vest in four equal installments on March 9 of 2027, 2028, 2029 and 2030. Vesting occurs only if he continues serving with the company through each scheduled vesting date as stated.

How do Rachit Jain’s new Schrodinger stock options vest over time?

The options granted on March 2, 2026 vest with 25% of the underlying shares on March 2, 2027. The remaining shares vest in equal monthly installments through March 2, 2030, subject to his continued service with Schrodinger throughout the vesting period.

Are the Schrodinger (SDGR) equity grants to Rachit Jain open-market purchases?

No, these are compensation-related grants, not market purchases. The Form 4 shows awards of stock options and RSUs at an exercise price of zero, reflecting equity incentives rather than cash-funded buying of shares in the open market.